Literature DB >> 7272559

Recent progress in the treatment of portwine staining by argon laser: some observations on the prognostic value of relative spectro-reflectance (RSR) and the histological classification of the lesions.

S Ohmori, C K Huang.   

Abstract

Over a period of more than three years 1264 patients with a portwine stain have been treated by argon laser. This form of therapy is more effective and worthwhile than the other procedures we have used in the past. The histological classification of the various types of portwine stain and the measurements of Spectro-reflectance (RSR) obtained by the spectrophotometric colour difference meter (Murakami) provide valuable and reliable prognostic criteria for this form of treatment.

Entities:  

Mesh:

Year:  1981        PMID: 7272559     DOI: 10.1016/0007-1226(81)90003-5

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  6 in total

1.  Dye laser treatment of port-wine stains.

Authors:  Y Bandoh; A Yanai; K Tsuzuki
Journal:  Aesthetic Plast Surg       Date:  1990       Impact factor: 2.326

Review 2.  Spectrophotometers for the clinical assessment of port-wine stain skin lesions: a review.

Authors:  Tom Lister; Philip Wright; Paul Chappell
Journal:  Lasers Med Sci       Date:  2010-01-20       Impact factor: 3.161

3.  Surgery for the extensive facial port-wine stain?

Authors:  L Clodius
Journal:  Aesthetic Plast Surg       Date:  1985       Impact factor: 2.326

4.  Ultrastructural observations in port wine stains.

Authors:  B V Schneider; Y Mitsuhashi; U W Schnyder
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

5.  Argon laser in the treatment of port wine stains.

Authors:  J A Carruth
Journal:  J R Soc Med       Date:  1984-09       Impact factor: 5.344

6.  Effect of laser therapy on plasma expression of VEGF and bFGF in infants with cutaneous hemangioma.

Authors:  Fagang Wang; Rongjian Xu; Qian Xu; Yongqian Cao; Li Lin; Wei Dang
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.